HAGERMAN ALLISON

PrivateCIK: 2103583
Location

SAN DIEGO, CA

HAGERMAN ALLISON enters ONCOLYTICS BIOTECH INC with 105.06K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderHAGERMAN ALLISONCIK 2103583
IssuerONCOLYTICS BIOTECH INCCIK 1129928
Officer· VP, Product Development
Since Feb 2026
105.06K
Baseline shares
100% direct
105.06K
Direct ownership
1 position
792.99K
Derivative underlying
8 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Shares

Direct
Shares owned105.06K
Total
105.06K direct105.06K
Derivative Holdings8

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

45K

Shares owned

N/A

Exercise price

3.40

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

240K

Shares owned

N/A

Exercise price

1.08

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

7.89K

Shares owned

N/A

Exercise price

2.66

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

250K

Shares owned

N/A

Exercise price

0.99

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

75.60K

Shares owned

N/A

Exercise price

1.13

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

21.70K

Shares owned

N/A

Exercise price

2.76

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

72.80K

Shares owned

N/A

Exercise price

1.91

Expiration

Exercise window

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

80K

Shares owned

N/A

Exercise price

2.31

Expiration

Exercise window

Total

Underlying

792.99K

Owned

0.00

HAGERMAN ALLISON — Initial Ownership Disclosure (Form 3) Filed Jan 2, 2026 | Finecho